3-Isopropyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, 95.0%, 250mg

2-Chloro-3,4-dihydroxybenzoic acid, 95.0%, 250mg

tert-Butyl-4-(isoquinolin-5-yl)piperazine-1-carboxylate, 97%, 100mg

4-(((2S,4S)-1-([1,1'-BIPHENYL]-4-YL)-5-ETHOXY-4-METHYL-5-OXOPENTAN-2-YL)AMINO)-4-OXOBUTANOIC ACID, 98%, 1mg

4-Bromo-3,5-dichlorophenol, 98%, 250mg

Ethyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97.0%, 5g

(R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl dicarbonate, 95.0%, 25g

Benzyl N-[(3-oxocyclobutyl)methyl]carbamate, 98%, 500mg

4-Chloro-2-methoxy-1-methylbenzene, 95.0%, 25g

6-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 5g

(6-Chlorobenzo[b]thiophen-2-yl)boronic acid, 95%, 250mg

Vierkantdose LOFT, Styrolacrylnitril (SAN), weiß, 1000 ml, L 150 x B 200 x H 48 mm, 1 Stück

Methyl 5-((3aR,4R,6aS)-rel-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate, 95.0%, 250mg